Search

Your search keyword '"Mieke D. Trip"' showing total 65 results

Search Constraints

Start Over You searched for: Author "Mieke D. Trip" Remove constraint Author: "Mieke D. Trip" Topic humans Remove constraint Topic: humans
65 results on '"Mieke D. Trip"'

Search Results

1. Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe

2. A rare variant in MCF2L identified using exclusion linkage in a pedigree with premature atherosclerosis

3. Gene-centric meta-analysis in 87,736 individuals of European ancestry identifies multiple blood-pressure-related loci

4. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility

5. Common genetic variants do not associate with CAD in familial hypercholesterolemia

6. Loci influencing blood pressure identified using a cardiovascular gene-centric array

7. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease

8. Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci

9. Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial

10. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

11. Genome-Wide Association Studies in Atherosclerosis

12. Myeloperoxidase is not associated with scintigraphic myocardial perfusion abnormalities in type 2 diabetic patients with mild stable anginal complaints

13. Assessment of carotid atherosclerosis in normocholesterolemic individuals with proven mutations in the low-density lipoprotein receptor or apolipoprotein B genes

14. Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy

15. Colesevelam Added to Combination Therapy With a Statin and Ezetimibe in Patients With Familial Hypercholesterolemia: A 12-Week, Multicenter, Randomized, Double-Blind, Controlled Trial

16. Prognostic value of myocardial perfusion scintigraphy in type 2 diabetic patients with mild, stable angina pectoris

17. Efficacy and safety of disodium ascorbyl phytostanol phosphates in men with moderate dyslipidemia

18. Atherogenic lipoprotein particle size and concentrations and the effect of pravastatin in children with familial hypercholesterolemia

19. Simvastatin with or without ezetimibe in familial hypercholesterolemia

20. A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia

21. Plant stanols do not restore endothelial function in pre-pubertal children with familial hypercholesterolemia despite reduction of low-density lipoprotein cholesterol levels

22. Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe

23. Effectiveness of Inhibition of Cholesteryl Ester Transfer Protein by JTT-705 in Combination With Pravastatin in Type II Dyslipidemia

24. Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia

25. Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy

26. Mutation in KERA identified by linkage analysis and targeted resequencing in a pedigree with premature atherosclerosis

27. A comparison of the efficacy and tolerability of titrate-to-goal regimens of simvastatin and fluvastatin: a randomized, double-blind study in adult patients at moderate to high risk for cardiovascular disease

28. A Frequent Mutation in the Lipoprotein Lipase Gene (D9N) Deteriorates the Biochemical and Clinical Phenotype of Familial Hypercholesterolemia

29. Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease

30. The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis

31. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture

32. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes

33. Large-Scale Gene-Centric Meta-Analysis across 39 Studies Identifies Type 2 Diabetes Loci

34. Frequent Mutation in the ABCC6 Gene (R1141X) Is Associated With a Strong Increase in the Prevalence of Coronary Artery Disease

35. Arterial stiffness is increased in families with premature coronary artery disease

36. Maps of open chromatin guide the functional follow-up of genome-wide association signals: application to hematological traits

37. Platelets in patients with premature coronary artery disease exhibit upregulation of miRNA340* and miRNA624*

38. Identification of candidate genes linking systemic inflammation to atherosclerosis ; results of a human in vivo LPS infusion study

39. Abnormal hemostatic parameters in patients with myocardial infarction but angiographically normal coronary arteries

40. Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function

41. Genetic Variation at the Phospholipid Transfer Protein Locus Affects Its Activity and High-Density Lipoprotein Size and Is a Novel Marker of Cardiovascular Disease Susceptibility

42. Long-term LDL-c lowering in heterozygous familial hypercholesterolemia normalizes carotid intima-media thickness

43. Atherosclerosis in Patients With Cyanotic Congenital Heart Disease

44. Correlation between HIV-1 seropositivity and prevalence of a gamma-secretase polymorphism in two distinct ethnic populations

45. ACAT Inhibition and Progression of Carotid Atherosclerosis in Patients With Familial Hypercholesterolemia The CAPTIVATE Randomized Trial

46. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism

47. Male-Specific Association between a gamma-Secretase Polymorphism and Premature Coronary Atherosclerosis

48. Current and future pharmacologic options for the management of patients unable to achieve low-density lipoprotein-cholesterol goals with statins

49. Diabetes mellitus type 2 is associated with higher levels of myeloperoxidase

50. Efficacy and safety of coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia

Catalog

Books, media, physical & digital resources